Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Pancreatic Neoplasms 9Peutz-Jeghers Syndrome 3Exocrine Pancreatic Insufficiency 2Pancreatic Intraductal Neoplasms 1Intraductal Papillary Mucinous Neoplasms 1Hereditary pancreatitis 1Hereditary Sensory and Autonomic Neuropathies 1Fanconi Anemia, Complementation Group D1 1Dysplastic Nevus Syndrome 1Diabetes Mellitus 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Breast Neoplasms 1

Interventions

olaparib 9Carboplatin 3talazoparib 1pembrolizumab 1liposomal doxorubicin 1iniparib 1Trabectedin 1Surveys and Questionnaires 1Secretin 1Paclitaxel 1Genotype 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1Biopsy, Fine-Needle 1ABT-767 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Secretin × Clear all
NCT00438906 2021-06-18

CAPS 3

Johns Hopkins University

Completed
200 enrolled
Classical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡